4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001209191-22-024130
President & CEO bought 10,000 shares at $8.40 ($84,000)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hirsch Andrew President & CEO | 2022-04-12 | Purchase | +10,000 | $8.40 | $84,000 | 10,000 | D |
| Open-market purchases · 10,000 sh · avg $8.40 · $84,000 | |||||||
Loading xslF345X03/doc4.xml…